Gene Panel Market Competitive Trend Analysis to 2025 | Development By Key Manufacturers - Illumina, Inc., Agilent Technologies, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Novogene Corporation., Personalis Inc., ArcherDX, Inc., QIAGEN, Integrated DNA T

The Insight Partners has announced the "Gene Panel Market Research Report 2018” The report focuses on key gene panel manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Get Sample PDF Copy @ http://bit.ly/2QoxKcy

The "Global Gene Panel Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global gene panel market with detailed market segmentation by product & services, technique, application, design, end-user and geography. The global gene panel market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The gene panel market is anticipated to grow with a significant rate in the coming years, owing to factors such as increasing prevalence of genetic diseases. In addition, cancer is the key factor for the growth of the Gene panel testing market. Moreover, growing technological advancements such as next generation sequencing (NGS) system, and the need for efficient prenatal diagnosis are significant factors that also fuel the growth of gene panel market in the coming years. On other hand the government initiatives in population sequencing are anticipated to offer more growth opportunities for the players operating in the global gene panel market.

Profiles of key gene panel manufacturing companies

1. Illumina, Inc.
2. Agilent Technologies
3. Eurofins Scientific
4. F. Hoffmann-La Roche Ltd
5. Novogene Corporation.
6. Personalis Inc.
7. ArcherDX, Inc.
8. QIAGEN
9. Integrated DNA Technologies, Inc.
10. BGI

Gene panel testing is known as an option for genetic testing and counseling associated to cancer risks. The Gene panel test is used to perform to analyze the multiple genes at once for the cancer-associated mutations. The test is capable to examine a several number of genes that can provide information related to the cancer and provide a secure diagnostics to help to prevent or stop the cancer to be spread.

The global gene panel market is segmented on the basis of product & services, technique, application, design, and end-user. The gene panel market is segmented into testing services and test kits, by product & services. On the basis of the technique, the gene panel market is bifurcated into hybridization-based approach and amplicon-based approach. Based on application, the gene panel market is classified as cancer risk assessment, diagnosis of congenital disorders, pharmacogenetics, and other applications.

The segment of cancer risk assessment is further classified into high-penetrance gene panels, syndrome-specific gene panels, high and moderate-penetrance gene panels and comprehensive cancer risk panels. On the design basis, the gene panel market is categorized into customized gene panels and predesigned gene panels. Based on end users, the gene panel market is classified as hospitals & diagnostic laboratories, research & academic institutes and pharmaceutical & biotechnology companies.

Buy the complete report with Comprehensive table of contents @ http://bit.ly/2PWobCd

North America is anticipated to capture largest market share and projected highest CAGR gene panel owing to growing clinical applications for next generation sequencing and increasing focus on market players for providing efficient gene panel services to researchers in the region. Moreover, growing government funding programs in genomic research also act as a driver foe the gene panel market in the forecast period. However, the Asia-Pacific region is expected to register the highest growth during the forecast period with the majority of growth primarily driven by growing geriatric population and increasing number of cancer cases in the region.

About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.